Skip to main content

LMR Partners LLP

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1578621 LONDON, X0

Position in UTHR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$9,746,219
+$2,268,394 QoQ
Shares Held
16,436
+7.1% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
12 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Derivatives in UTHR

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$18,975,360
PutShares
32,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

LMR Partners LLP holds $45,048,985 across 4 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (21.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 UTHR
UNITED THERAPEUTICS Corp
This page
16,436 $9,746,219

All Filings in UTHR

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $9,746,219 16,436
2026-03-31 $18,975,360 32,000
2025-12-31 $7,477,825 15,347
2025-12-31 $21,780,075 44,700
2025-09-30 $32,446,854 77,400
2025-09-30 $168,103,210 401,000
2025-03-31 $1,541,350 5,000
2024-12-31 $3,528,400 10,000
2024-09-30 $12,398,910 34,600
2024-06-30 $9,556,500 30,000
2024-03-31 $10,659,008 46,400
2023-12-31 $10,202,896 46,400
2022-12-31 $2,629,340 9,455
2022-09-30 $337,939 1,614
2022-06-30 $638,113 2,708